Gene · 70
Papers1,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of human tear proteome reveals differentially abundance proteins in thyroid-associated ophthalmopathy. | PeerJ | 2022 | 35846879 | PubTator, text mining | PubMed |
| Molecular genetic mechanisms of congenital heart disease. | Curr Opin Genet Dev | 2022 | 35816939 | PubTator, text mining | PubMed |
| Myocardial Injury Caused by Chronic Alcohol Exposure-A Pilot Study Based on Proteomics. | Molecules | 2022 | 35807529 | PubTator, text mining | PubMed |
| Genome-wide identification of long noncoding RNA genes and their potential association with mammary gland development in water buffalo. | Anim Biosci | 2022 | 35798030 | PubTator, text mining | PubMed |
| Case Report: A Chinese Family of Hypertrophic Cardiomyopathy Caused by a Novel Splicing Mutation in the FLNC Gene. | Front Genet | 2022 | 35795207 | PubTator, text mining | PubMed |
| Coexistent Diabetes Is Associated With the Presence of Adverse Phenotypic Features in Patients With Hypertrophic Cardiomyopathy. | Diabetes Care | 2022 | 35789379 | PubTator, text mining | PubMed |
| Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy. | Front Cell Dev Biol | 2022 | 35784482 | PubTator, text mining | PubMed |
| Aberrant miR-874-3p/leptin/EGFR/c-Myc signaling contributes to nasopharyngeal carcinoma pathogenesis. | J Exp Clin Cancer Res | 2022 | 35778755 | PubTator, text mining | PubMed |
| Proteomic Profiling of Small Extracellular Vesicles Isolated from the Plasma of Vietnamese Patients with Non-Small Cell Lung Cancer Reveals Some Potential Biomarkers. | Asian Pac J Cancer Prev | 2022 | 35763629 | PubTator, text mining | PubMed |
| Exploring the Potential of Symmetric Exon Deletion to Treat Non-Ischemic Dilated Cardiomyopathy by Removing Frameshift Mutations in TTN. | Genes (Basel) | 2022 | 35741855 | PubTator, text mining | PubMed |
| Exome sequencing in multiplex families with left-sided cardiac defects has high yield for disease gene discovery. | PLoS Genet | 2022 | 35737725 | PubTator, text mining | PubMed |
| A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches. | J Cardiovasc Dev Dis | 2022 | 35735803 | PubTator, text mining | PubMed |
| Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging. | J Cardiovasc Dev Dis | 2022 | 35735798 | PubTator, text mining | PubMed |
| Cytoplasmic Beta and Gamma Actin Isoforms Reorganization and Regulation in Tumor Cells in Culture and Tissue. | Front Pharmacol | 2022 | 35721191 | PubTator, text mining | PubMed |
| MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations. | BMC Cardiovasc Disord | 2022 | 35717150 | PubTator, text mining | PubMed |
| Engineering extracellular vesicles by three-dimensional dynamic culture of human mesenchymal stem cells. | J Extracell Vesicles | 2022 | 35716062 | PubTator, text mining | PubMed |
| Human intracardiac SSEA4+CD34- cells show features of cycling, immature cardiomyocytes and are distinct from Side Population and C-kit+CD45- cells. | PLoS One | 2022 | 35709180 | PubTator, text mining | PubMed |
| Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants. | Circulation | 2022 | 35708014 | PubTator, text mining | PubMed |
| Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy. | J Cardiovasc Magn Reson | 2022 | 35692049 | PubTator, text mining | PubMed |
| Transcriptional Effects of Candidate COVID-19 Treatments on Cardiac Myocytes. | Front Cardiovasc Med | 2022 | 35686037 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/70/papers?page=21